Skip to content
10-K

Annual Report

KYTHERA BIOPHARMACEUTICALS INC

0001047469-15-001515

← back to feed
Filed
Mar 2, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2014 · Feb 23, 2015 22.76M sh
Capex FY 2014 · Dec 31, 2014 $2.06M
Capex FY 2014 · Dec 31, 2013 $42K
Cash And Equivalents FY 2014 · Dec 31, 2014 $29.23M
Cash And Equivalents FY 2014 · Dec 31, 2013 $111.52M
Stockholders Equity FY 2014 · Dec 31, 2014 $59.44M
Stockholders Equity FY 2014 · Dec 31, 2013 $149.84M
Current Liabilities FY 2014 · Dec 31, 2014 $20.63M
Current Liabilities FY 2014 · Dec 31, 2013 $17.58M
Total Liabilities FY 2014 · Dec 31, 2014 $43.99M
Total Liabilities FY 2014 · Dec 31, 2013 $23.57M
Current Assets FY 2014 · Dec 31, 2014 $101.16M
Current Assets FY 2014 · Dec 31, 2013 $173.28M
Total Assets FY 2014 · Dec 31, 2014 $103.43M
Total Assets FY 2014 · Dec 31, 2013 $173.41M
Rd Expense FY 2014 · Dec 31, 2014 $47.84M
Rd Expense FY 2014 · Dec 31, 2013 $33.97M
Net Income FY 2014 · Dec 31, 2014 −$24.22M
Net Income FY 2014 · Dec 31, 2014 −$135.62M
Net Income FY 2014 · Sep 30, 2014 −$22.47M
Net Income FY 2014 · Jun 30, 2014 −$19.48M
Net Income FY 2014 · Mar 31, 2014 −$69.45M
Net Income FY 2014 · Dec 31, 2013 −$14.02M
Net Income FY 2014 · Dec 31, 2013 −$51.91M
Net Income FY 2014 · Sep 30, 2013 −$11.51M
Net Income FY 2014 · Jun 30, 2013 −$12.26M
Net Income FY 2014 · Mar 31, 2013 −$14.13M
Operating Income FY 2014 · Dec 31, 2014 −$131.65M
Operating Income FY 2014 · Dec 31, 2013 −$50.07M